Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Contact information

Email
rachel.roberts@ndm.ox.ac.uk

Research groups

Malaria Programme: Pre-erythrocytic Vaccines

Rachel Roberts

Recent publications

Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial.
Journal article

Folegatti PM. et al, (2020), The Lancet. Infectious diseases, 20, 816 - 826
Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
Journal article

Folegatti PM. et al, (2019), Vaccines, 7, 40 - 40
Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal
Journal article

Venkatraman N. et al, (2019), The Journal of Infectious Diseases, 219, 1187 - 1197
Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line
Journal article

Folegatti PM. et al, (2019), Vaccines, 7, 33 - 33
First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children
Journal article

Tiono AB. et al, (2018), PLOS ONE, 13, e0208328 - e0208328

More publications